Literature DB >> 21592590

Effect of Ginkgo biloba extract on endotoxin-induced labyrinthitis.

Chul Ho Jang1, Yong Bum Cho, Jun Sung Kim, Sung Woo Cho, Hyung Chae Yang, Kee Hong Jung, Jae Young Kim, Cheol Hee Choi, Yong Lim, Haekyun Park, Sung In Kang.   

Abstract

OBJECTIVE: There are no reports on the therapeutic effect of Ginkgo biloba extract (GBE) on otitis media-induced labyrinthitis. The present study examined whether GBE can protect against cochlear damage induced by intratympanic instillation of lipopolysaccharide (LPS)-induced labyrinthitis.
MATERIALS AND METHODS: Experiments were performed in 20 healthy young male guinea pigs. The control group (n=10) received an intratympanic instillation of LPS (20 μl, 3mg/ml). The experimental group (n=10) received intratympanic instillation of LPS immediately after instillation of GBE (10mg/kg) and then experimental groups received GBE (100mg/kg) by intraperitoneal injection every day for 3 days. Instillation of LPS or LPS immediately after GBE was done in the right ear; the untreated left ear was considered normal. Physiological and morphological changes were evaluated.
RESULTS: Statistical analysis of treatment of GBE revealed significantly less hearing loss than LPS group (p<0.05). The ratio of the value of cochlear blood flow (CBF) compared to untreated left side was significantly higher in the GBE treated group than in the LPS-treated group (p<0.05). This result indicated the recovery of CBF in GBE treated group compared to LPS treated group. In the LPS group, scanning electron microscopy revealed hair cell damage with edema. Missing stereocilia in the third layer of the outer hair cell was revealed. However, both the inner hair cells and the outer hair cells had normal appearance in the GBE group. LPS group showed that cochlear Evans blue extravasation was increased strongly in the stria vascularis, spiral limbus, and in the spiral ligament compared with the GBE treated group.
CONCLUSION: GBE significantly minimizes cochlear damage against LPS-induced otitis media with labyrinthitis in a guinea pig model. GBE has potential as an adjunctive therapy to antibiotics in the treatment of acute otitis media with complicated labyrinthitis.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592590     DOI: 10.1016/j.ijporl.2011.04.003

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  4 in total

1.  The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial.

Authors:  Ja-Won Koo; Mun Young Chang; Sung-Cheol Yun; Tae Su Kim; Soo-Keun Kong; Jong Woo Chung; Eui-Kyung Goh
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-11       Impact factor: 2.503

2.  Combining Cochlear Analysis and Auditory Evoked Potentials in a Beluga Whale With High-Frequency Hearing Loss.

Authors:  Maria Morell; Stephen A Raverty; Jason Mulsow; Martin Haulena; Lance Barrett-Lennard; Chad A Nordstrom; Frederic Venail; Robert E Shadwick
Journal:  Front Vet Sci       Date:  2020-11-04

3.  Preventive Effects of Ginkgo-Extract EGb 761® on Noise Trauma-Induced Cochlear Synaptopathy.

Authors:  Konstantin Tziridis; Holger Schulze
Journal:  Nutrients       Date:  2022-07-22       Impact factor: 6.706

4.  Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement.

Authors:  Camila L Radunz; Cristina E Okuyama; Fátima C A Branco-Barreiro; Regina M S Pereira; Susana N Diniz
Journal:  Braz J Otorhinolaryngol       Date:  2019-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.